Queen's University, Kingston, Ontario
12
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
17%
2 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The Effectiveness of Topical Prilocaine-Lidocaine Cream Plus Acetaminophen and Naproxen Compared to Lidocaine Injection Plus Acetaminophen and Naproxen to Manage Pain During IntraUterine Device Insertion
Role: collaborator
Virtual Reality for Anxiety Management in Persons With Amyotrophic Lateral Sclerosis
Role: collaborator
Emergency Department Assessment of Right Ventricular Function and Size in the Post Cardiac Arrest Patient
Role: collaborator
A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.
Role: collaborator
Fatigue Management Programs for People With MS
Role: collaborator
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Role: collaborator
Canadian Sudden Cardiac Arrest Network
Role: collaborator
The Study Guide Cluster Randomized Control Trial
Role: collaborator
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Role: collaborator
Effects of Inspiratory Muscle Training on Dyspnea Perception During Exercise in Patients With COPD
Role: collaborator
Transcranial Magnetic Treatment (TMS) in Unipolar Depression
Role: collaborator
Transcranial Magnetic Stimulation in Bipolar Depression
Role: collaborator
All 12 trials loaded